An open-label, 3-period, fixed-sequence study to evaluate the pharmacokinetics Elbasvir/Grazoprevir fixed-dose combination co-administered with Famotidine or Pantoprazole in healthy volunteers
Latest Information Update: 14 Mar 2016
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Famotidine; Pantoprazole
- Indications Hepatitis C
- Focus Pharmacokinetics
- 14 Mar 2016 New trial record